Notes / Company

Wanbury Ltd.

WANBURY BSE 524212 ISIN INE107F01022 Pharmaceuticals

Fundamentals

Market cap: ₹895 cr
P/E: 20.83×
ROE: 51.51%
Debt / equity: 2.92
52-week range: 161.50 — 320.95

Research on Tijori Finance

The timeline — 1 note on Wanbury Ltd.

June 2026

02 Jun 26 · 12:24 PM IST Brief

Brief · Earnings · Micro cap

Wanbury's full-year profit jumps 117% on better mix and procurement savings

Net profit surged to ₹66.1 crore for FY26, though a West Asia-related export disruption dented the final quarter.

Verify on exchange BSE filings for WANBURY NSE filings for WANBURY Tijori Finance company page